EnClear Therapies’ system designed to treat amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases was one of five first-place winners of the Massachusetts Life Sciences Center (M2D2) $200K Challenge. Cambridge, Mass.-based EnClear Therapies’ device-based system was designed to halt the progression of neurodegenerative diseases by removing toxic proteins that build up in the brain and […]
Neurological
Welcome to MassDevice's Neurological Hub, your resource for the latest news in the neurological device space. Stay informed about the innovations and business news shaping the neurological industry.
🧠 Narrow your focus with these categories:
Neuromodulation/Neurostimulation | Bioelectronic Medicine | Pain Management | Brain-Computer Interfaces
Here are the top neurological device features from MassDevice and its sister publications (and scroll down to read the latest cardiology device news from MassDevice):
+ 7 brain-computer interface companies you need to know
+ Brain breakthroughs: Aprinoia Therapeutics’ harnesses AI and strategic partnerships to propel neurodegenerative disease research
+ Natalizumab and PML: The complex dance of benefit and risk for MS
Latest Neurological News
MicroPort Scientific joins $20m Series C for Rapid Medical
MicroPort Scientific has joined a $20 million Series C round for neurovascular device maker Rapid Medical. Israel-based Rapid Medical said that proceeds from the now closed Series C round will be used to support the completion of its TIGER U.S. IDE study and further commercial growth of its minimally invasive stroke treatment and prevention devices. The […]
Medtronic inks deal to distribute Alpha Omega’s neurosurgical nav tool
Medtronic (NYSE:MDT) has inked an agreement with Israel-based medtech developer Alpha Omega to market its surgical navigation products designed for procedures in the brain, according to a recent Globes report. Prior to the agreement, Alpha Omega’s devices were offered as independent products and were mostly marketed to hospitals in Israel, according to the report. Alpha Omega […]
InVivo Therapeutics releases 12-month Inspire study results
InVivo Therapeutics (NSDQ:NVIV) yesterday presented twelve-month results from the single-arm INSPIRE study of its neuro-spinal scaffold. The Cambridge, Mass.-based company’s neuro-spinal scaffold is a novel, biodegradable device designed to be surgically implanted following acute spinal cord injuries to act as a physical substrate for nerve sprouting. Results from the trial were presented at the 2019 AANS Meeting in […]
Terumo’s Microvention touts Web aneurysm embolization study
Terumo (OTC:TRUMY;TYO:4543) subsidiary MicroVention today released results from the WEB-IT pivotal trial of its Web aneurysm embolization system. Results from the trial were published in the online edition of the Journal of NeuroInterventional Surgery, the Aliso Viejo, Calif.-based company said. The trial enrolled a total of 150 patients across 21 U.S. centers and six international centers, MicroVention said. […]
Brainlab recalls Spine & Trauma 3D Nav over display inaccuracies
The FDA this week issued a Class I recall for select Brainlab Spine & Trauma 3D navigation software products over a potential to display incorrect information during surgery that may affect the procedure. Class I designations, the FDA’s most severe classification, are used when there is a reasonable probability that product use could cause serious […]
Masimo touts O3 cerebral oxygenation study results
Masimo (NSDQ:MASI) today released results from a study seeking to establish a normal range of values for cerebral oxygenation and explore the relationship between cerebral oxygenation and other physical and hemodynamic characteristics using Masimo’s O3 Regional Oximetry. Results from the study were published in the journal Anaesthesia and Intensive Care, the Irvine, Calif.-based company said. Masimo […]
FDA warns against unapproved concussion diagnosis devices
The FDA today warned consumers against using medical devices purported to assess head injuries, saying tht only five companies are cleared to market such devices in the U.S. and that they should only be used by physicians. “The FDA has identified several manufacturers that were marketing medical devices for concussion diagnosis, treatment or management without […]
Synchron’s thought-to-text tech starts clinical trial
Synchron said it has begun the first clinical trial for its neural interface technology designed to restore communication to people with severe paralysis. The trial will measure the safety of the company’s “thought-to-text” technology by assessing its Stentrode implant in combination with BrainOS software and the stability of high-fidelity signals from the brain to external communications […]
Silk Road Medical clears $109m in IPO
Silk Road Medical (NSDQ:SILK) said yesterday that it cleared just more than $109 million in its initial public offering, including a fully subscribed underwriters option. The $20-per-share flotation grossed $120 million, Sunnyvale, Calif.-based Silk Road said. The company is developing a neuroprotection and stent system called Enroute as an aid to transcarotid artery revascularization procedures. Silk […]
Silk Road Medical upsizes IPO
Silk Road Medical today boosted the size of its pending initial public offering to as much as $120 million. When it registered the IPO in March, Silk Road said it could fetch as much as $86 million. But last week the Sunnyvale, Calif.-based company cut the range, saying it planned to float nearly 4.7 million […]